desk
Share
News Topical, Digital Desk : India's renowned pharmaceutical company, Jubilant Pharmova, has released its results for the third quarter of the current financial year. In an exchange filing, the company stated that its profits have declined significantly. Consolidated profits have declined from ₹101 crore to ₹56 crore. Consolidated earnings have increased from ₹1,821 crore to ₹2,123 crore.
The company's consolidated EBITDA increased from ₹280 crore to ₹290 crore. Conversely, its consolidated EBITDA margin declined from 15.4% to 13.6%. All figures are annualized.
Shares of Jubilant Pharmova Ltd. fell today
Thursday, February 6th. The stock fell 1.68%, or ₹16.40, to close at ₹957.45 on the NSE. The stock's high during the day was ₹975 and its lowest level was ₹930.75, while the previous close was ₹973.85.
The company's market cap is approximately ₹15.16 thousand crore, and the stock has a P/E ratio of 31.84. Its 52-week high was ₹1,248 and its lowest was ₹802. The stock fluctuated throughout the day, and some recovery from the lows was seen in the afternoon, but ultimately traded in the red.
Read More: What is the repo rate? How does your EMI increase or decrease? Learn everything here.
--Advertisement--
